Projects Funded

The University of Texas

The project will develop the first Breast-Skin microfluidic experimental platform to dynamically and spatially measure cancer cell invasion into the dermal layer, skin lymphatics, and breast vasculature characteristic of IBC. This platform will be employed to determine the cellular components and tissue properties that drive IBC cancer cell migration to enable development of potential treatments and preventive strategies.

The University of Texas

PhD. student conducting the research with Marissa N. Rylander, PhD. to develop the first Breast-Skin microfluidic experimental platform to dynamically and spatially measure cancer cell invasion into the dermal layer, skin lymphatics, and breast vasculature characteristic of IBC. This platform will be employed to determine the cellular components and tissue properties that drive IBC cancer cell migration to enable development of potential treatments and preventive strategies.

The James, The Ohio State University
Dr. Lori Gill-Grennan Inflammatory Breast Cancer Fund

This funding supports education, research, and clinical activities for inflammatory breast cancer and/or program promotion or operational costs related to the inflammatory breast cancer program at Ohio State University. The research funded under this effort is Dr. Daniel Stover.

Vanderbilt-Ingram Cancer Center

Justin Balko, Pharm.D., Ph.D.  and Carlos L. Arteaga, M.D. The goal of this grant is to utilize existing models of inflammatory breast cancer.  In addition,  Vanderbilt investigators were the first to identify and explore a particular variance – amplification of the JAK2 gene.

Baylor College of Medicine

Sponsorship for this CME aimed to enhance the knowlege of oncologists in the management of advanced breasta cancer and how to implement the emerging therapies and cuttin edge techniques into day to day practice. 

The University of Texas MD Anderson Cancer Center

Matching grant for this annual fundraiser that provides support for patient programs, research, prevention and education at MD Anderson — and 100% of funds raised by participants directly support MD Anderson’s mission to end cancer.

The University of Texas MD Anderson Cancer Center

This two-day meeting is targeted for clinical investigators, physicians, basic researchers, nurses, patient advocates and institutions aiming to pioneer IBC clinics in their geographic regions, to enhance their knowledge and to facilitate collaboration to accelerate clinical therapy and research trial development beneficial for patients with IBC. We expect new ideas and collaborations from this meeting to lead to improvement of disease outcome, such as survival or tumor response, over the next 3 years.

Vanderbilt-Ingram Cancer Center

Justin Balko, Pharm.D., Ph.D.  and Carlos L. Arteaga, M.D. The goal of this grant is to utilize existing models of inflammatory breast cancer.  In addition,  Vanderbilt investigators were the first to identify and explore a particular variance – amplification of the JAK2 gene.

Vanderbilt-Ingram Cancer Center

Justin Balko, Pharm.D., Ph.D.  and Carlos L. Arteaga, M.D. The goal of this grant is to utilize existing models of inflammatory breast cancer.  In addition,  Vanderbilt investigators were the first to identify and explore a particular variance – amplification of the JAK2 gene.

The University of Texas MD Anderson Cancer Center

Matching grant for this annual fundraiser that provides support for patient programs, research, prevention and education at MD Anderson — and 100% of funds raised by participants directly support MD Anderson’s mission to end cancer.

Dana Farber Cancer Institute

Matching grant for this annual fundraiser that benefits Dana-Farber Cancer Institute’s lifesaving mission to provide compassionate patient care and groundbreaking cancer research for children and adults.